Cladribine-related myelodysplastic syndrome in Langerhans cell histiocytosis

Pediatr Int. 2019 Apr;61(4):419-421. doi: 10.1111/ped.13792. Epub 2019 Apr 17.

Authors

Yukiko Oh¹, Tomomi Hayase¹, Takane Ito¹, Yuta Kawahara¹, Akira Morimoto¹

Affiliation

¹ Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.

PMID: 30993805
DOI: 10.1111/ped.13792

No abstract available

Keywords: Langerhans cell histiocytosis; cladribine; cyclophosphamide; myelodysplastic syndrome; therapy related.

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Cladribine / adverse effects*
Cladribine / therapeutic use
Female
Histiocytosis, Langerhans-Cell / complications
Histiocytosis, Langerhans-Cell / drug therapy*
Humans
Infant
Myelodysplastic Syndromes / chemically induced*
Myelodysplastic Syndromes / complications

Substances

Antineoplastic Agents
Cladribine